Conflict of interest: none.
Repeat post-op voiding trials: An inconvenient correlate with success
Article first published online: 27 AUG 2013
© 2013 Wiley Periodicals, Inc.
Neurourology and Urodynamics
Volume 33, Issue 8, pages 1225–1228, November 2014
How to Cite
Ferrante, K. L., Kim, H.-Y., Brubaker, L., Wai, C. Y., Norton, P. A., Kraus, S. R., Shepherd, J., Sirls, L. T., Nager, C. W. and for the Urinary Incontinence Treatment Network (2014), Repeat post-op voiding trials: An inconvenient correlate with success. Neurourol. Urodyn., 33: 1225–1228. doi: 10.1002/nau.22489
Eric Rovner led the peer-review process as the Associate Editor responsible for the paper.
- Issue published online: 13 OCT 2014
- Article first published online: 27 AUG 2013
- Manuscript Accepted: 31 JUL 2013
- Manuscript Received: 23 MAY 2013
- National Institute of Diabetes and Digestive and Kidney Disease
- National Institutes of Health
- midurethral sling;
- stress urinary incontinence;
- voiding dysfunction
This study examined the association between the need for a repeat voiding trial after midurethral sling (MUS) surgery and 1-year success rates.
We conducted this secondary analysis of the participants in the Urinary Incontinence Treatment Network trial of midurethral sling (TOMUS) study which compared retropubic versus transobturator MUS. A standard voiding trial was attempted on all subjects. The “repeat voiding trial” group included subjects discharged with catheterization. All others were considered “self voiding.” Success rates between the groups at 1-year were compared, followed by multivariate analyses controlling for previously reported clinical predictors of success.
Most women (76%) were self-voiding, while 24% required a repeat voiding trial. The objective success rate at 1-year was 85.8% in the repeat voiding trial group and 75.3% in the self-voiding group (P = 0.01). Subjective success rate at 1-year was 61.0% in the repeat voiding trial group and 55.1% in the self-voiding group (P = 0.23). Women in the repeat voiding trial group continued to demonstrate greater objective success than the self-voiding group in multivariate analysis that controlled for previous incontinence surgery, pad weight, urethral mobility, urge score, and type of MUS (P = 0.04, OR 1.82, 95% CI 1.03–3.22).
Women who require a repeat voiding trial following MUS surgery have greater objective success at 1-year postoperatively when compared to those who are self-voiding at the time of discharge. These results may help reassure women who require catheterization after MUS surgery that their outcome is not compromised by this immediate transient post-operative result. Neurourol. Urodynam. 33:1225–1228, 2014. © 2013 Wiley Periodicals, Inc.